Although oral P2Y12 inhibitors are key in the management of patients with non-ST elevation acute coronary syndrome (NSTE-ACS), the optimal timing of their administration is not well defined.
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome
Tarantini, Giuseppe;Mojoli, Marco;Babuin, Luciano;Fovino, Luca Nai;Masiero, Giulia;Esposito, Giovanni;Martinato, Matteo;Azzolina, Danila;Gregori, Dario;
2020
Abstract
Although oral P2Y12 inhibitors are key in the management of patients with non-ST elevation acute coronary syndrome (NSTE-ACS), the optimal timing of their administration is not well defined.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.pdf
Accesso riservato
Tipologia:
Published (publisher's version)
Licenza:
Accesso privato - non pubblico
Dimensione
453.83 kB
Formato
Adobe PDF
|
453.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
